Rosalind Carter

Rosalind Carter is an epidemiologist in ICAP's Monitoring, Evaluation and Research (MER)Unit, with special focus on perinatal prevention (PMTCT) and pediatric issues.

In this role, Dr. Carter is responsible for overseeing the design, and evaluation of monitoring systems related to perinatal prevention and pediatric care at all ICAP-supported programs.  In close collaboration with the ICAP-NY PMTCT program officer, she worked on the development and recent implementation of a set of comprehensive PMTCT indicators to monitor and evaluate programs across ICAP country programs and provides ongoing technical assistance and support to country programs in developing PMTCT, Maternity and HIV Exposed Infant registers and patient level reporting systems for pediatric inpatient testing, early infant diagnostic testing, and HIV-exposed infant followup. Rosalind also serves as the MER liaison to the Pediatric Centers of Excellence in Lusaka and Livingstone, Zambia.

Dr. Carter has a substantial scientific leadership role in the MTCT Plus Initiative, supervising and conducting epidemiologic analyses of program data in collaboration with the director of the MTCT Plus Initiative, ICAP colleagues and the Data Management Center at John Snow International, Inc. She represents the MTCT-Plus Initiative Program in the KIDS ART-LINC collaboration, a consortium of pediatric HIV programs in sub-Saharan Africa.    

Before joining ICAP, Dr. Carter was the project director of two large multi-center CDC-sponsorted studies: PACTS-HOPE, a longitudinal study of HIV perinatally infected and exposed children at five public hospitals in New York City and MIRIAD, one of the first studies to evaluate the feasibility of offering HIV rapid testing to women in labor and delivery in the United States.

Rosalind Carter was an epidemic intelligence Service officer with the U.S. Centers for Disease Control and Prevention, assigned to the Bureau of Communicable Disease at the New York City Department of Health and Mental Hygiene. Her work included establishing hospital and laboratory-based surveillance systems for antibiotic-resistant bacteria, investigating food and waterborne disease outbreaks and conducting studies of pneumococcal disease among HIV-infected patients at long term health facilities in NYC. 

Dr. Carter received her doctorate in epidemiologic science from the University of Michigan, Rackham Graduate School of Arts and Sciences, and a bachelor's degree from Harvard and Radcliffe Colleges.